|
Next-Generation Personalized Neuroblastoma Therapy (Nepenthe) |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Factors Affecting Parental Satisfaction, Anxiety and Comprehension of the Informed Consent in Pediatric Oncology Clinical Trials |
University of California, San Diego |
Northwestern Mutual Foundation |
|
Engager T Cells: A Novel Immunotherapeutic for AML |
University of Michigan |
Northwestern Mutual Foundation |
|
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell |
The Johns Hopkins University School of Medicine |
Northwestern Mutual Foundation |
|
Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan |
Northwestern Mutual Foundation |
|
Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center |
Northwestern Mutual Foundation |
|
Optimizing Engager T-cells for CD19+ Malignancies |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Arterial Stiffness in Children who Recently Completed Cancer Therapy |
University of North Carolina |
Northwestern Mutual Foundation |
|
Nitrosative Stress And Symptom Severity During Childhood Leukemia Treatment |
Duke University Medical Center |
Northwestern Mutual Foundation |
|
Reversing the Oncogenic Roles of Misdirected Chromatin Remodeling in Synovial Sarcoma |
Lucile Packard Children’s Hospital at Stanford University School of Medicine |
Northwestern Mutual Foundation |